Search for: "Gate Pharmaceuticals" Results 41 - 60 of 231
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Sep 2011, 12:50 pm by The Legal Blog
Justice Dalveer Bhandari Supreme Court of India In a landmark judgment in C. [read post]
22 Jun 2010, 8:49 am by Jerry Brito
  He also addresses the future of books and potential tipping points that could prompt changes in copyright law, citing the Google Books project and pharmaceuticals in the developing world. [read post]
23 May 2018, 11:37 am by Juvan Bonni
Adrian Johns: Piracy: The Intellectual Property Wars from Gutenberg to Gates Prof. [read post]
20 Apr 2012, 5:02 pm by Colin O'Keefe
Also, we have an LXBN TV today on the pharmaceutical sales rep/overtime case in the Supreme Court. [read post]
7 Jun 2010, 4:08 pm by Robert Elliott, J.D.
  The worker  was preparing an aircraft at Terminal 3 at Heathrow, when a 70-tonne 'pushback tug,” used to move aircraft from the departure gate, finished maneuvering a plane into position and was leaving the stand, when it knocked the worker to the ground and ran over his right leg. [read post]
28 Oct 2017, 2:04 pm by Chuck Cosson
Content Moderation Questions I was privy to a discussion at Google in the spring of 2004 regarding the acceptance of ads from online pharmaceuticals. [read post]
3 Oct 2018, 3:48 am by Dennis Crouch
Samsung Electronics America, Inc. et al., No. 18-189 (PTAB judges as principal officers; retroactive CBM reviews) Regeneron Pharmaceuticals, Inc. v. [read post]
1 Jun 2011, 7:47 am
Under the terms of an FTC consent order (CCH Trade Regulation Reporter ¶16,376), the combination was permitted to proceed, subject to divestitures aimed at preserving competition in multiple U.S. markets for animal pharmaceuticals and vaccines.The May 19 decision in Golden Gate Pharmacy Services, Inc. v. [read post]
21 May 2009, 12:42 pm
Gates did not qualify for the "solely for the purpose of investment" exemption to the pre-merger notification requirements because he intended to participate in the basic business decisions of ICOS through his longstanding membership on the board of directors of ICOS, a pharmaceutical company headquartered in Bothell, Washington. [read post]
8 Jul 2011, 8:52 am by Expert Witness Guru
MERRELL DOW PHARMACEUTICALS, INC., laying down the foundation of admissibility of scientific expert testimony. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
” According to Gates, pharmaceutical companies are not refusing to share COVID-19 vaccine formulas. [read post]
10 Jul 2023, 7:50 am by Dan Farber
As to COVID, he has said, ““intelligence agencies, pharmaceutical companies, social media titans, medical bureaucracies, mainstream media and the military … are using a health crisis to impose totalitarian control worldwide. [read post]
20 Mar 2017, 6:39 pm by John Collins
John Collins and Natalie ShoolmanThe Federal Court of Australia has handed down its first detailed damages decision in a long time in a patent infringement claim against a generic pharmaceutical company. [read post]
1 Jul 2014, 11:24 am by Shea Denning
Is the gate swinging wide open for DRE and HGN testimony or is it guarded by a skeptical judge? [read post]
14 Apr 2015, 10:01 pm by James Andrews
The norovirus vaccine furthest along in development is being made by Japanese pharmaceutical company Takeda Pharmaceuticals, Lopman said. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
” According to Gates, pharmaceutical companies are not refusing to share COVID-19 vaccine formulas. [read post]
10 Sep 2020, 6:23 pm by Lisa Larrimore Ouellette
” These killed bits of virus are then, through additional steps, used as the basis for making a pharmaceutically acceptable vaccine.The process—like egg farming itself—is labor intensive. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]